Stock HEPA HEPION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hepion Pharmaceuticals, Inc.

Equities

HEPA

US4268973025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.3 USD +4.84% Intraday chart for Hepion Pharmaceuticals, Inc. +3.17% -59.88%
Apr. 22 Sector Update: Health Care Stocks Increase Late Afternoon MT
Apr. 22 Sector Update: Health Care MT

Evolution of the average Target Price on Hepion Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ff6e85b5.hxN4blGe3jzyqhgHNaLY2pgwHd1eaNCZmdmwmXicNGc.4UsZJAHbiHGA_ntvU-i9lvMCSrlrRbfDrbPeoA_KZR_YJRslC-6sCMGSVQ~fc1ec4e5f028604982645e692230df4a

Analyst Recommendations on Hepion Pharmaceuticals, Inc.

Cantor Fitzgerald Starts Hepion Pharmaceuticals at Overweight With $3.50 Price Target MT
HEPION PHARMACEUTICALS : Roth Capital Adjusts Price Target on Hepion Pharmaceuticals to $8 From $14, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.3
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hepion Pharmaceuticals, Inc.

Cantor Fitzgerald

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HEPA Stock
  4. Consensus Hepion Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW